학술논문
Oral Fludarabine and Intravenous Rituximab (FR) for Chronic Lymphocytic Leukemia (CLL): Long Term Outcomes and Secondary Malignancies in 673 Patients Treated in British Columbia (BC)
Document Type
Abstract
Author
Source
In Blood 13 November 2019 134 Supplement 1:4300-4300
Subject
Language
ISSN
0006-4971